JP4825138B2 - 薬剤ディスペンサー用カウンター - Google Patents
薬剤ディスペンサー用カウンター Download PDFInfo
- Publication number
- JP4825138B2 JP4825138B2 JP2006552694A JP2006552694A JP4825138B2 JP 4825138 B2 JP4825138 B2 JP 4825138B2 JP 2006552694 A JP2006552694 A JP 2006552694A JP 2006552694 A JP2006552694 A JP 2006552694A JP 4825138 B2 JP4825138 B2 JP 4825138B2
- Authority
- JP
- Japan
- Prior art keywords
- wheel
- count
- kick
- dose counter
- teeth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims description 216
- 229940079593 drug Drugs 0.000 title claims description 203
- 230000007246 mechanism Effects 0.000 claims description 42
- 230000005540 biological transmission Effects 0.000 claims description 17
- 230000033001 locomotion Effects 0.000 claims description 13
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000002585 base Substances 0.000 description 43
- 239000003937 drug carrier Substances 0.000 description 37
- 238000013523 data management Methods 0.000 description 24
- 229940112141 dry powder inhaler Drugs 0.000 description 23
- 230000004044 response Effects 0.000 description 21
- 238000000034 method Methods 0.000 description 18
- 230000036961 partial effect Effects 0.000 description 14
- -1 polypropylene Polymers 0.000 description 14
- 230000002441 reversible effect Effects 0.000 description 11
- 239000000546 pharmaceutical excipient Substances 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 210000003195 fascia Anatomy 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 238000004891 communication Methods 0.000 description 8
- 238000004804 winding Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000002093 peripheral effect Effects 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229940071648 metered dose inhaler Drugs 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000012937 correction Methods 0.000 description 4
- 238000004377 microelectronic Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 229960004017 salmeterol Drugs 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 3
- 229960004436 budesonide Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 229960002848 formoterol Drugs 0.000 description 3
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000037452 priming Effects 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 229960002052 salbutamol Drugs 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 210000003371 toe Anatomy 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 229950000339 xinafoate Drugs 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229940092705 beclomethasone Drugs 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000013479 data entry Methods 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229960002714 fluticasone Drugs 0.000 description 2
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 2
- 229960000289 fluticasone propionate Drugs 0.000 description 2
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 238000012384 transportation and delivery Methods 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- YREYLAVBNPACJM-UHFFFAOYSA-N 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol Chemical compound CC(C)(C)NCC(O)C1=CC=CC=C1Cl YREYLAVBNPACJM-UHFFFAOYSA-N 0.000 description 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- 125000005975 2-phenylethyloxy group Chemical group 0.000 description 1
- PVXFCOPBOYHONF-UHFFFAOYSA-N 3-ethyl-1,3-benzothiazol-2-one Chemical compound C1=CC=C2SC(=O)N(CC)C2=C1 PVXFCOPBOYHONF-UHFFFAOYSA-N 0.000 description 1
- LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- IJVCSMSMFSCRME-KBQPJGBKSA-N Dihydromorphine Chemical compound O([C@H]1[C@H](CC[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O IJVCSMSMFSCRME-KBQPJGBKSA-N 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010041012 Integrin alpha4 Proteins 0.000 description 1
- HUYWAWARQUIQLE-UHFFFAOYSA-N Isoetharine Chemical compound CC(C)NC(CC)C(O)C1=CC=C(O)C(O)=C1 HUYWAWARQUIQLE-UHFFFAOYSA-N 0.000 description 1
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 1
- 206010024971 Lower respiratory tract infections Diseases 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 206010069119 Tracheal dilatation Diseases 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229940057282 albuterol sulfate Drugs 0.000 description 1
- BNPSSFBOAGDEEL-UHFFFAOYSA-N albuterol sulfate Chemical compound OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 BNPSSFBOAGDEEL-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 1
- 229960002576 amiloride Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 229950000210 beclometasone dipropionate Drugs 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 229960003728 ciclesonide Drugs 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 229940109248 cromoglycate Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011982 device technology Methods 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001022 fenoterol Drugs 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000008011 inorganic excipient Substances 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940125798 integrin inhibitor Drugs 0.000 description 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 description 1
- 229960001888 ipratropium Drugs 0.000 description 1
- 229960001268 isoetarine Drugs 0.000 description 1
- 229960001317 isoprenaline Drugs 0.000 description 1
- 229960004958 ketotifen Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- LMOINURANNBYCM-UHFFFAOYSA-N metaproterenol Chemical compound CC(C)NCC(O)C1=CC(O)=CC(O)=C1 LMOINURANNBYCM-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 229960001664 mometasone Drugs 0.000 description 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229960004398 nedocromil Drugs 0.000 description 1
- RQTOOFIXOKYGAN-UHFFFAOYSA-N nedocromil Chemical compound CCN1C(C(O)=O)=CC(=O)C2=C1C(CCC)=C1OC(C(O)=O)=CC(=O)C1=C2 RQTOOFIXOKYGAN-UHFFFAOYSA-N 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229960004708 noscapine Drugs 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 229960002657 orciprenaline Drugs 0.000 description 1
- 239000008012 organic excipient Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- NVOYVOBDTVTBDX-PMEUIYRNSA-N oxitropium Chemical compound CC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1 NVOYVOBDTVTBDX-PMEUIYRNSA-N 0.000 description 1
- 229960000797 oxitropium Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 1
- 229960000395 phenylpropanolamine Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 229960002720 reproterol Drugs 0.000 description 1
- WVLAAKXASPCBGT-UHFFFAOYSA-N reproterol Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CCCNCC(O)C1=CC(O)=CC(O)=C1 WVLAAKXASPCBGT-UHFFFAOYSA-N 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 229950004432 rofleponide Drugs 0.000 description 1
- IXTCZMJQGGONPY-XJAYAHQCSA-N rofleponide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3O[C@@H](CCC)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O IXTCZMJQGGONPY-XJAYAHQCSA-N 0.000 description 1
- 229960005018 salmeterol xinafoate Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 1
- 229940110309 tiotropium Drugs 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- 229960000859 tulobuterol Drugs 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06M—COUNTING MECHANISMS; COUNTING OF OBJECTS NOT OTHERWISE PROVIDED FOR
- G06M1/00—Design features of general application
- G06M1/14—Design features of general application for transferring a condition from one stage to a higher stage
- G06M1/16—Design features of general application for transferring a condition from one stage to a higher stage self-operating, e.g. by Geneva mechanism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0043—Non-destructive separation of the package, e.g. peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/02—Pill counting devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
- A61M15/0025—Mouthpieces therefor with caps
- A61M15/0026—Hinged caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/007—Mechanical counters
- A61M15/0071—Mechanical counters having a display or indicator
- A61M15/0075—Mechanical counters having a display or indicator on a disc
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/0081—Locking means
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06M—COUNTING MECHANISMS; COUNTING OF OBJECTS NOT OTHERWISE PROVIDED FOR
- G06M1/00—Design features of general application
- G06M1/04—Design features of general application for driving the stage of lowest order
- G06M1/045—Design features of general application for driving the stage of lowest order for dial, pointer, or similar type indicating means
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06M—COUNTING MECHANISMS; COUNTING OF OBJECTS NOT OTHERWISE PROVIDED FOR
- G06M1/00—Design features of general application
- G06M1/22—Design features of general application for visual indication of the result of count on counting mechanisms, e.g. by window with magnifying lens
- G06M1/24—Drums; Dials; Pointers
- G06M1/248—Discs
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06M—COUNTING MECHANISMS; COUNTING OF OBJECTS NOT OTHERWISE PROVIDED FOR
- G06M1/00—Design features of general application
- G06M1/22—Design features of general application for visual indication of the result of count on counting mechanisms, e.g. by window with magnifying lens
- G06M1/26—Aligning means
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06M—COUNTING MECHANISMS; COUNTING OF OBJECTS NOT OTHERWISE PROVIDED FOR
- G06M3/00—Counters with additional facilities
- G06M3/02—Counters with additional facilities for performing an operation at a predetermined value of the count, e.g. arresting a machine
- G06M3/025—Counters with additional facilities for performing an operation at a predetermined value of the count, e.g. arresting a machine with dial, pointer, or similar type indicating means
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06M—COUNTING MECHANISMS; COUNTING OF OBJECTS NOT OTHERWISE PROVIDED FOR
- G06M3/00—Counters with additional facilities
- G06M3/12—Counters with additional facilities for preventing incorrect actuation, e.g. for preventing falsification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Biophysics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Vending Machines For Individual Products (AREA)
Description
Claims (19)
- 薬剤ディスペンサーに使用される投与量カウンターであって、
前記投与量カウンターは、
第1の回転軸を中心として回転するようにした第1のカウント車輪であって、カウント符号と、この第1のカウント車輪を前記第1の回転軸を中心として回転駆動させるため環状に配置された一連の主駆動歯と、を有するものと;
第1の回転軸を中心として回転するようにした第2のカウント車輪であって、カウント符号と環状に配置された一連の二次駆動歯とを有し、それぞれのカウント符号が同軸に配置されるように前記第1のカウント車輪と同軸に配置されているものと;
前記第1の回転軸からオフセットされた位置に設けられた第2の回転軸を中心として回転するようにしたキック車輪であって、環状に配置され、前記第2のカウント車輪の二次駆動歯と歯合する一連のキック歯を有し、該キック歯の回転動作によって前記第2のカウント車輪の回転動作を生じさせるものと;を具備してなり;
前記第1のカウント車輪が更に前記キック車輪のキック歯と間欠的に歯合する固定割送り歯を有し、この間欠的歯合がなされたときにのみ、第1のカウント車輪の回転動作からキック車輪の回転動作が生じるようになっており、
前記投与量カウンターは、前記第1および第2のカウント車輪のカウント符号が回転可能な表示領域を有し、
前記第2のカウント車輪は、前記表示領域を閉じる閉塞位置に移動自在なシャッターを有し、
前記投与量カウンターは、前記表示領域に前記カウント符号のカウントシーケンスを表示するように構成、配列され、このカウントシーケンスの終点で前記シャッターをその閉塞位置に移動させるようになっており、
前記投与量カウンターは、前記シャッターがその閉塞位置にあるときに、前記第1のカウント車輪が前記キック車輪を介して前記第2のカウント車輪を回転駆動させることができないように構成、配置されていることを特徴とする投与量カウンター。 - 前記第1のカウント車輪のカウント符号は円環状の上面に設けられており、前記第2のカウント車輪はその円環内に配置されている請求項1記載の投与量カウンター。
- 前記第1のカウント車輪は円環である請求項1または2記載の投与量カウンター。
- 前記第2のカウント車輪のカウント符号は円形状の上面に設けられており、前記第1のカウント車輪の上面の内部環状空所内に受理されている請求項2または請求項2に従属する場合の請求項3記載の投与量カウンター。
- 前記シャッターは、前記第2のカウント車輪の上面によって形成されている請求項4記載の投与量カウンター。
- 前記シャッターは、前記第1のカウント車輪のカウント符号に重なるように前記上面から径方向外側へ向かって延出している請求項5記載の投与量カウンター。
- 前記主駆動歯が駆動車輪と連続的に歯合していて、該駆動車輪が使用時に薬剤ディスペンサーの操作機構と連結し、この操作機構の作動が投与量カウンターに伝達されて前記駆動車輪が回転し、前記第1のカウント車輪を回転駆動させ、前記シャッターがその閉塞位置にあるときにはキック車輪を介した第1のカウント車輪から第2のカウント車輪への駆動伝達が解除され、前記駆動車輪が更に前記第1のカウント車輪を回転駆動させたときにも前記シャッターはその閉塞位置に維持されるようになっている請求項1ないし4のいずれかに記載の投与量カウンター。
- 第2の回転軸が第1の回転軸から或る距離を以って離間されており、前記キック車輪のキック歯によって画成される回転路が、第1のカウント車輪の主駆動歯によって画成される回転路によって包含されるようになっている請求項1ないし7のいずれかに記載の投与量カウンター。
- 前記割送り歯が第1のカウント車輪の周辺又はその近傍に固定されており、第1のカウント車輪の回転によって、この割送り歯をキック車輪のキック歯と歯合させ、この歯合を第1のカウント車輪の回転サイクルの特定の時点で、かつ、第1のカウント車輪の一回転ごとに生じさせるようになっている請求項1ないし8のいずれかに記載の投与量カウンター。
- 薬剤ディスペンサーでの使用に適し、薬剤ディスペンサーのサブアッセンブリーとして提供される請求項1ないし9のいずれかに記載の投与量カウンター。
- 覗き窓を有するハウジングを備え、該覗き窓を介してカウントシーケンスを視認可能にした請求項1ないし10のいずれかに記載の投与量カウンター。
- 前記第2のカウント車輪が前記シャッターと一体に形成されている請求項1ないし11のいずれかに記載の投与量カウンター。
- 前記シャッターが前記第1のカウント車輪のカウント符号に重なっている請求項1ないし12のいずれかに記載の投与量カウンター。
- 前記シャッターがその閉塞位置にあるときに、前記キック歯の、前記割送り歯及び/又は二次駆動歯との歯合が生じないようになっている請求項1ないし13のいずれかに記載の投与量カウンター。
- 一連のキック歯又は二次駆動歯に隙間が設けられていて、前記シャッターがその閉塞位置にあるときに歯合を不可能にした請求項14記載の投与量カウンター。
- 前記隙間が二次駆動歯に設けられている請求項15記載の投与量カウンター。
- 薬剤ディスペンサーでの使用に適し、薬剤ディスペンサーのサブアッセンブリーとして提供される投与量カウンターであって、第1および第2のカウント車輪とキック車輪と駆動車輪が回転自在に載置されているベースプレートと、第1および第2のカウント車輪とキック車輪と駆動車輪の上方で該ベースプレートに載置されているベゼルと、を有し、該ベゼルがカウントシーケンスを視認するための覗き窓を有している請求項7記載の投与量カウンター。
- 前記駆動車輪が第1および第2の回転軸からオフセットされた位置に設けられた第3の回転軸を中心として回転するようになっており、これらの第1、第2および第3の回転軸は実質的に平行である請求項7または請求項7に従属する場合の請求項8ないし17のいずれかに記載の投与量カウンター。
- 前記第1のカウント車輪は内面と外面を有する環状部材を備え、該内面と外面にはそれぞれ割送り歯と主駆動歯が設けられており、前記第2のカウント車輪は、前記二次駆動歯が前記環状部材の内面と対向するように該環状部材に入れ子式に配置されており、前記キック車輪は前記環状部材の内面と前記二次駆動歯の間に配置されている請求項1ないし18のいずれかに記載の投与量カウンター。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0403394.0 | 2004-02-16 | ||
GB0403394A GB0403394D0 (en) | 2004-02-16 | 2004-02-16 | Counter for use with a medicament dispenser |
GB0418264.8 | 2004-08-16 | ||
GB0418264A GB0418264D0 (en) | 2004-08-16 | 2004-08-16 | Counter for use with a medicament dispenser |
PCT/GB2005/000531 WO2005079727A2 (en) | 2004-02-16 | 2005-02-15 | Counter for use with a medicament dispenser |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007526562A JP2007526562A (ja) | 2007-09-13 |
JP4825138B2 true JP4825138B2 (ja) | 2011-11-30 |
Family
ID=34889131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006552694A Active JP4825138B2 (ja) | 2004-02-16 | 2005-02-15 | 薬剤ディスペンサー用カウンター |
Country Status (19)
Country | Link |
---|---|
US (1) | US8113199B2 (ja) |
EP (1) | EP1730676B1 (ja) |
JP (1) | JP4825138B2 (ja) |
KR (1) | KR101105909B1 (ja) |
AU (1) | AU2005215216B2 (ja) |
BR (1) | BRPI0507714B8 (ja) |
CA (1) | CA2555347A1 (ja) |
CY (1) | CY1114641T1 (ja) |
DK (1) | DK1730676T3 (ja) |
ES (1) | ES2435397T3 (ja) |
HK (1) | HK1101722A1 (ja) |
IL (1) | IL177042A (ja) |
MX (1) | MXPA06009133A (ja) |
NO (1) | NO338541B1 (ja) |
NZ (1) | NZ548888A (ja) |
PL (1) | PL1730676T3 (ja) |
PT (1) | PT1730676E (ja) |
SG (2) | SG150524A1 (ja) |
WO (1) | WO2005079727A2 (ja) |
Families Citing this family (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0302812D0 (en) * | 2003-02-07 | 2003-03-12 | Wickham Mark D | Metering valves for dispensers |
GB0315509D0 (en) | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
GB0317374D0 (en) | 2003-07-24 | 2003-08-27 | Glaxo Group Ltd | Medicament dispenser |
US7100530B2 (en) * | 2003-12-15 | 2006-09-05 | Trudell Medical International, Inc. | Dose indicating device |
US6877246B1 (en) * | 2003-12-30 | 2005-04-12 | Kimberly-Clark Worldwide, Inc. | Through-air dryer assembly |
GB2414187B (en) | 2004-05-21 | 2007-03-07 | Bespak Plc | Dispensing apparatus |
GB2417024B (en) * | 2004-08-11 | 2007-01-03 | Bespak Plc | Improvements in metering valves for dispensers |
GB0418278D0 (en) | 2004-08-16 | 2004-09-15 | Glaxo Group Ltd | Medicament dispenser |
FR2883400B1 (fr) * | 2005-03-16 | 2007-06-15 | Valois Sas | Dispositif d'indication de doses pour distribuer des produits fluides ou pulverulents |
GB2429166A (en) * | 2005-07-27 | 2007-02-21 | Cambridge Consultants | Inhaler counter |
GB0515584D0 (en) | 2005-07-28 | 2005-09-07 | Glaxo Group Ltd | Medicament dispenser |
CA2620861C (en) | 2005-08-31 | 2016-07-05 | T2 Biosystems, Inc. | Nmr device for detection of analytes |
GB0519151D0 (en) * | 2005-09-20 | 2005-10-26 | Aventis Pharma Ltd | Inhaler |
GB0600070D0 (en) * | 2006-01-04 | 2006-02-15 | Campling Nicholas J | Dose counter |
GB0605150D0 (en) * | 2006-03-14 | 2006-04-26 | Glaxo Group Ltd | Counter For Use With A Medicament Dispenser |
WO2007124406A2 (en) * | 2006-04-21 | 2007-11-01 | 3M Innovative Properties Company | Dose counter |
FR2900259B1 (fr) * | 2006-04-24 | 2008-10-10 | Valois Sas | Indicateur de doses pour dispositif de distribution de produit fluide |
DE102006043637A1 (de) | 2006-05-18 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Zerstäuber |
GB2438396B (en) | 2006-05-26 | 2008-10-01 | Bespak Plc | Improvements in or relating to dispensing apparatus |
GB0610541D0 (en) | 2006-05-26 | 2006-07-05 | Bespak Plc | Improvements in or relating to dispensing apparatus |
GB0613472D0 (en) * | 2006-07-06 | 2006-08-16 | Glaxo Group Ltd | A counter and a recorder for a pill dispenser |
FR2904297B1 (fr) * | 2006-07-25 | 2008-10-10 | Valois Sas | Dispositif de distribution de produit fluide. |
FR2904229B1 (fr) * | 2006-07-25 | 2008-10-10 | Valois Sas | Dispositif de distribution de produit fluide. |
GB0622827D0 (en) | 2006-11-15 | 2006-12-27 | Glaxo Group Ltd | Sheet driver for use in a drug dispenser |
ES2569359T3 (es) * | 2007-07-06 | 2016-05-10 | Vectura Delivery Devices Limited | Inhalador |
FR2924351B1 (fr) * | 2007-12-03 | 2011-09-30 | Valois Sas | Dispositif de distribution de produit fluide |
WO2009103711A1 (en) * | 2008-02-18 | 2009-08-27 | Glaxo Group Limited | Actuation counter |
CN102065940B (zh) | 2008-05-07 | 2014-06-11 | Map药物公司 | 带锁定机构的剂量计数器 |
DE102008039376B4 (de) * | 2008-08-22 | 2010-12-23 | Hengstler Gmbh | Vorrichtung zur induktiven Abtastung der Teilstriche eines mechanischen Rollenzählwerkes bei Zählern aller Art |
DE102008039377A1 (de) | 2008-08-22 | 2010-02-25 | Hengstler Gmbh | Vorrichtung zur Abtastung der Teilstriche eines mechanischen Rollenzählwerks bei Zählern aller Art |
US8887722B2 (en) * | 2008-09-26 | 2014-11-18 | Oriel Therapeutics, Inc. | Inhaler mechanisms with radially biased piercers and related methods |
CN102159269B (zh) | 2008-09-26 | 2014-05-07 | 奥里尔治疗公司 | 一种带有双穿刺元件的干燥粉末吸入器以及相关装置和方法 |
CA2732842C (en) | 2008-09-26 | 2018-01-09 | Oriel Therapeutics, Inc. | Inhalers with airway disks having discrete airway channels and related disks and methods |
EP2328645B1 (en) * | 2008-10-01 | 2015-11-11 | Oriel Therapeutics, Inc. | Dry powder inhalers with rotating piercing mechanisms and related devices and methods |
EP2341966A4 (en) * | 2008-10-08 | 2016-07-13 | Astrazeneca Ab | INHALER WITH HANDLED ADVERTISING MATERIALS |
FR2940642B1 (fr) | 2008-12-30 | 2014-02-21 | Valois Sas | Compteur pour dispositif de distribution de produit fluide ou pulverulent |
FR2940698B1 (fr) * | 2008-12-30 | 2011-06-10 | Valois Sas | Compteur pour dispositif de distribution de produit fluide ou pulverulent |
FR2940699B1 (fr) * | 2008-12-30 | 2011-03-04 | Valois Sas | Compteur pour dispositif de distribution de produit fluide ou pulverulent |
GB0904040D0 (en) | 2009-03-10 | 2009-04-22 | Euro Celtique Sa | Counter |
DK2239003T3 (en) | 2009-03-30 | 2015-02-02 | Arven Ilac Sanayi Ve Ticaret As | The counting device to a dry powder inhaler device |
US8333729B2 (en) * | 2009-04-07 | 2012-12-18 | Polybiotics Llc | Multi-dose delivery system |
FR2944707B1 (fr) * | 2009-04-28 | 2013-08-09 | Valois Sas | Compteur pour dispositif de distribution de produit fluide ou pulverulent. |
PL2432532T3 (pl) * | 2009-05-18 | 2015-01-30 | Norton Healthcare Ltd | Inhalator do suchego proszku |
WO2010133323A1 (en) * | 2009-05-18 | 2010-11-25 | Norton Healthcare Limited | Dry-powder inhaler |
ES2543386T3 (es) * | 2009-05-18 | 2015-08-18 | Norton Healthcare Limited | Inhalador de polvo seco |
PL2432530T3 (pl) * | 2009-05-18 | 2015-04-30 | Norton Healthcare Ltd | Inhalator do suchego proszku |
US9125999B2 (en) * | 2009-05-18 | 2015-09-08 | Adamis Pharmaceuticals Corporation | Dry powder inhaler dose counters |
JP5330916B2 (ja) * | 2009-07-23 | 2013-10-30 | 日立オートモティブシステムズ株式会社 | 粉末薬剤投与器 |
US8539945B2 (en) * | 2009-08-18 | 2013-09-24 | Teva Pharmaceutical Industries Ltd. | Dose counter and recording method |
US8434421B2 (en) * | 2009-09-22 | 2013-05-07 | Janet L. Fagan | Manually settable tamper resistant indicator device |
US9345848B2 (en) | 2009-10-20 | 2016-05-24 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. | Dry powder inhaler |
GB0921555D0 (en) * | 2009-12-09 | 2010-01-27 | 3M Innovative Properties Co | Dose indicator |
TR200909791A2 (tr) * | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Salmeterol ve flutikazon içeren farmasötik bileşim@ |
DE102009060773B4 (de) * | 2009-12-30 | 2011-11-17 | Hengstler Gmbh | Vorrichtung zur Abtastung der Teilstriche eines mechanischen Rollenzählwerks bei Zählern aller Art mit RFID-Technik |
EP2566551B1 (en) * | 2010-04-13 | 2016-03-30 | Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. | Inhalation device |
SI2558148T1 (sl) * | 2010-04-13 | 2016-10-28 | Sima Patent Ve Lisanslama Hizmetleri Ltd.Sti. | Gumb ustnika inhalatorja suhega praška |
EA027141B1 (ru) * | 2010-04-13 | 2017-06-30 | Сима Патент Ве Лисанслама Хизметлери Лтд. Сти. | Кнопочное устройство мундштука ингалятора сухого порошка |
EP2566546B1 (en) * | 2010-04-13 | 2016-03-30 | Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. | Dry powder inhaler mouthpiece button |
JP5873477B2 (ja) * | 2010-04-13 | 2016-03-01 | シマ パテント ヴェ リサンスラマヒズメトレリ リミテッド シルケティ | 乾燥粉末形態の薬剤の送達に使用する吸入器 |
US9125795B2 (en) * | 2010-07-06 | 2015-09-08 | Tania Degian | Blood sugar management system |
JP5830258B2 (ja) | 2011-03-17 | 2015-12-09 | オリンパス株式会社 | 手術支援システム及び術具 |
JP6284884B2 (ja) | 2011-11-25 | 2018-02-28 | ビルギチ,マフムト | 吸入装置 |
US20150306322A9 (en) * | 2012-01-23 | 2015-10-29 | Sanofi Sa | Inhalation Device |
WO2013110609A1 (en) * | 2012-01-23 | 2013-08-01 | Sanofi Sa | Dose counting mechanism for an inhalation device and inhalation device |
US9668939B2 (en) | 2012-02-02 | 2017-06-06 | Becton Dickinson Holdings Pte. Ltd. | Adaptor for coupling with a medical container |
SG192310A1 (en) | 2012-02-02 | 2013-08-30 | Becton Dickinson Holdings Pte Ltd | Adaptor for coupling to a medical container |
SG192312A1 (en) | 2012-02-02 | 2013-08-30 | Becton Dickinson Holdings Pte Ltd | Adaptor for coupling to a medical container |
GB2502791B (en) | 2012-06-06 | 2014-08-20 | Consort Medical Plc | Dose indicator device |
EP2692328A1 (en) | 2012-08-03 | 2014-02-05 | Becton Dickinson France | Dose counting device for coupling with a medical container |
US11246800B2 (en) * | 2012-10-05 | 2022-02-15 | Alixa Rx, Llc | Locking canister for dispensing medications |
EP2735300A1 (en) | 2012-11-26 | 2014-05-28 | Becton Dickinson France | Adaptor for multidose medical container |
GB201223008D0 (en) * | 2012-12-20 | 2013-01-30 | Euro Celtique Sa | Counter |
GB201304784D0 (en) * | 2013-03-15 | 2013-05-01 | Euro Celtique Sa | Dispenser |
AU353853S (en) | 2013-04-11 | 2014-02-25 | Glaxo Group Ltd | Inhaler |
CN104340581B (zh) * | 2013-07-30 | 2017-09-19 | 鸿富锦精密工业(深圳)有限公司 | 自动取药装置及方法 |
JP1526207S (ja) | 2013-08-05 | 2015-06-15 | ||
USD744087S1 (en) | 2013-10-01 | 2015-11-24 | Mahmut Bilgic | Dry powder inhaler |
DE102014114462A1 (de) * | 2013-10-15 | 2015-04-16 | Alfred Von Schuckmann | Zählwerk und Handgerät mit Zählwerk |
GB2522664B (en) | 2014-01-31 | 2016-05-04 | Consort Medical Plc | Dose counter and dispensing apparatus |
WO2016059645A1 (en) | 2014-10-14 | 2016-04-21 | Cadila Healthcare Limited | A dose counter |
GB201421983D0 (en) * | 2014-12-10 | 2015-01-21 | Coalesce Product Dev Ltd | Improvements in counting devices |
US10252843B2 (en) * | 2015-02-07 | 2019-04-09 | Life Boost Inc. | Nutritional supplements travel dispenser |
JP2018509153A (ja) | 2015-03-11 | 2018-04-05 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | Tslp結合タンパク質 |
EP3359532A1 (en) | 2015-10-06 | 2018-08-15 | GlaxoSmithKline Intellectual Property Development Limited | Biaryl pyrazoles as nrf2 regulators |
EP3371167A1 (en) | 2015-10-06 | 2018-09-12 | GlaxoSmithKline Intellectual Property Development Limited | Arylcyclohexyl pyrazoles as nrf2 regulators |
AU2017210033B2 (en) | 2016-01-21 | 2022-09-29 | T2 Biosystems, Inc. | NMR methods and systems for the rapid detection of bacteria |
JP7026632B2 (ja) * | 2016-03-15 | 2022-02-28 | ナイキ イノベイト シーブイ | 自動化されたフットウェア・プラットフォームのための原点復帰機構 |
GB201610450D0 (en) * | 2016-06-15 | 2016-07-27 | Tech Partnership The Plc | Counting mechanism |
DE112017004217T5 (de) * | 2016-08-25 | 2019-05-16 | Validose, Inc. | System und Verfahren zur kontrollierten medizinischen Therapie |
WO2018055527A1 (en) | 2016-09-20 | 2018-03-29 | Glaxosmithkline Intellectual Property (No.2) Limited | Trpv4 antagonists |
CN109790116B (zh) | 2016-09-20 | 2022-10-28 | 葛兰素史密斯克莱知识产权(第2 号)有限公司 | Trpv4拮抗剂 |
TW201825458A (zh) | 2016-09-20 | 2018-07-16 | 英商葛蘭素史克智慧財產(第二)有限公司 | Trpv4拮抗劑 |
US20200031820A1 (en) | 2016-12-12 | 2020-01-30 | Glsxosmithkline Intellectual Property Development Limited | 3-carboxylic acid pyrroles as nrf2 regulators |
EP3551621A1 (en) | 2016-12-12 | 2019-10-16 | GlaxoSmithKline Intellectual Property Development Limited | N-aryl pyrazoles as nrf2 regulators |
EP3555088B1 (en) | 2016-12-14 | 2021-11-24 | GlaxoSmithKline Intellectual Property Development Limited | Bisaryl amides as nrf2 regulators |
JP2020502123A (ja) | 2016-12-14 | 2020-01-23 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | Nrf2アクチベーターとしてのビスアリール複素環 |
JP2020502129A (ja) | 2016-12-14 | 2020-01-23 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | Nrf2アクチベーターとしての3−オキソ−1,4−ジアゼピニル化合物 |
US11059816B2 (en) | 2016-12-15 | 2021-07-13 | Glaxosmithkline Intellectual Property Development Limited | Ether linked triazoles as NRF2 activators |
WO2019116231A1 (en) | 2017-12-11 | 2019-06-20 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome |
JP2021505636A (ja) | 2017-12-11 | 2021-02-18 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | 急性肺傷害、急性呼吸促迫症候群および多臓器不全症候群の処置のためのnrf2アクチベーター |
GB201720989D0 (en) | 2017-12-15 | 2018-01-31 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
MX2020007521A (es) | 2018-01-17 | 2022-12-05 | Glaxosmithkline Ip Dev Ltd | Inhibidores de pi4kiii. |
US12016998B2 (en) | 2018-05-11 | 2024-06-25 | Biocorp Production S.A. | Handheld metered dose inhaler |
EP3796906A1 (en) | 2018-05-23 | 2021-03-31 | GlaxoSmithKline Intellectual Property Management Limited | Indanes as nrf2 activators |
EP3840803A4 (en) * | 2018-09-10 | 2022-05-18 | Cipla Limited | SINGLE CUP STRIP DISPENSER |
WO2020058823A1 (en) | 2018-09-17 | 2020-03-26 | Lupin, Inc. | Dose indicator assembly for a medicament dispenser |
US20220134027A1 (en) * | 2019-02-06 | 2022-05-05 | Lupin Inc. | Dose Feedback Mechanisms and Assemblies for User Feedback |
CN110197552A (zh) * | 2019-05-06 | 2019-09-03 | 石翊鹏 | 一种适用于装配在机械电子设备的传动装置 |
GB201908536D0 (en) | 2019-06-13 | 2019-07-31 | Glaxosmithkline Ip Dev Ltd | Compounds |
EP4038549A1 (en) | 2019-10-04 | 2022-08-10 | Lupin Limited | Event status apparatuses and related devices, systems, and methods |
CN114786750B (zh) | 2019-12-18 | 2024-06-28 | 马库斯·梅兹格 | 吸入器 |
CA3186551A1 (en) | 2020-07-23 | 2022-01-27 | Lupin Inc. | Dose counter assemblies for medicament dispensers |
JP6901180B1 (ja) | 2020-11-19 | 2021-07-14 | ニップファーマ株式会社 | 薬剤吸入器及びカウンタ機構 |
WO2022175425A1 (en) | 2021-02-22 | 2022-08-25 | Glaxosmithkline Intellectual Property Development Limited | Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection |
WO2022179967A1 (en) | 2021-02-23 | 2022-09-01 | Glaxosmithkline Intellectual Property (No.2) Limited | Vadadustat for treating covid-19 in a hospitalized subject |
DE202022001505U1 (de) | 2022-07-07 | 2022-09-09 | Markus Mezger | lnhalator zur Verabreichung pulverförmiger Trockensubstanzen |
CN219375748U (zh) * | 2022-11-09 | 2023-07-21 | 传思生物公司 | 计数机构及吸入装置 |
DE202023001974U1 (de) | 2023-09-20 | 2023-12-14 | Markus Mezger | Respiratorischer Pfad eines lnhalators zur Verabreichung pulverförmiger Trockensubstanzen |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4525373Y1 (ja) * | 1967-03-22 | 1970-10-05 | ||
JPS4990567A (ja) * | 1972-12-06 | 1974-08-29 | ||
WO2004001664A1 (en) * | 2002-06-21 | 2003-12-31 | Glaxo Group Limited | Actuation indicator for a dispensing device |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE500836A (ja) * | ||||
US2550103A (en) * | 1946-11-02 | 1951-04-24 | Veeder Root Inc | Shutter mechanism |
GB1290484A (ja) | 1968-10-02 | 1972-09-27 | ||
AU6168869A (ja) | 1968-10-02 | 1971-04-08 | ||
GB1317315A (en) | 1970-12-17 | 1973-05-16 | English Numbering Machines | Mechanical impulse counter |
SE448277B (sv) | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
GB8713353D0 (en) | 1987-06-08 | 1987-07-15 | Scient Generics Ltd | Magnetic article surveillance systems |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
EP0565583B1 (en) | 1991-01-04 | 1997-04-09 | Scientific Generics Limited | Remotely readable data storage devices and apparatus |
DE69323897T2 (de) | 1992-12-18 | 1999-11-04 | Schering Corp., Kenilworth | Inhalator für pulverförmige medikamente |
FR2721106B1 (fr) * | 1994-06-10 | 1996-09-13 | Step | Compteur de doses pour inhalateurs. |
US5482030A (en) | 1994-06-13 | 1996-01-09 | Klein; David | Aerosol and non-aerosol spray counter |
US5702244A (en) | 1994-06-15 | 1997-12-30 | Thermal Energy Systems, Incorporated | Apparatus and method for reducing particulate emissions from combustion processes |
SE9404140D0 (sv) * | 1994-11-29 | 1994-11-29 | Astra Ab | Dose indicating device |
GB9506909D0 (en) | 1995-04-04 | 1995-05-24 | Scient Generics Ltd | Spatial magnetic interrogation system |
FI102875B (fi) | 1995-11-10 | 1999-03-15 | Orion Yhtymae Oy | Jauheinhalaattori |
CA2392466C (en) | 1995-12-07 | 2004-05-04 | Jago Research Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
PL185384B1 (pl) | 1996-02-21 | 2003-04-30 | Schering Corp | Inhalator proszku |
FR2750780B1 (fr) | 1996-07-05 | 1998-10-30 | Valois | Compteur de doses |
GB2320489A (en) | 1996-12-20 | 1998-06-24 | Norton Healthcare Ltd | Inhaler dose counter |
SE9700939D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler III |
SE9700938D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler II and a method of construction thereof |
TW533865U (en) * | 1997-06-10 | 2003-05-21 | Glaxo Group Ltd | Dispenser for dispensing medicament and actuation indicating device |
WO1999036115A2 (en) | 1998-01-16 | 1999-07-22 | 1263152 Ontario Inc. | Indicating device for use with a dispensing device |
US6142339A (en) | 1998-01-16 | 2000-11-07 | 1263152 Ontario Inc. | Aerosol dispensing device |
GB9807558D0 (en) | 1998-04-09 | 1998-06-10 | Bason Neil P | An indicator device |
US6336453B1 (en) | 1999-04-30 | 2002-01-08 | Trudell Medical International | Indicating device for aerosol container |
US6082358A (en) | 1998-05-05 | 2000-07-04 | 1263152 Ontario Inc. | Indicating device for aerosol container |
DE29814647U1 (de) | 1998-08-14 | 1999-12-23 | Josef Wischerath Gmbh & Co. Kg, 50259 Pulheim | Inhalator mit einer Dosierzähleinrichtung |
IT1312426B1 (it) | 1999-06-30 | 2002-04-17 | Microspray Delta Spa | Distributore di dosi di un liquido,con dispositivo per il conteggio di un elevato numero di dosi erogate |
FR2799858B1 (fr) | 1999-10-19 | 2002-01-18 | Valois Sa | Compteur de doses et distributeur de produit fluide incorporant un tel compteur |
GB9924949D0 (en) | 1999-10-22 | 1999-12-22 | Innovata Biomed Ltd | Inhaler |
SE515858C2 (sv) | 1999-11-26 | 2001-10-22 | Ernst Hoerlins Ingenjoersbyra | Räkneverk samt spraydosinhalator med räkneverket |
GB2364649A (en) | 2000-05-17 | 2002-02-06 | Orion Corp | Inhaler with Dose Counter |
PE20020075A1 (es) | 2000-06-23 | 2002-02-05 | Norton Healthcare Ltd | Dispositivo contador de dosis para inhalador de medicamento |
WO2002026301A1 (en) * | 2000-09-29 | 2002-04-04 | Pa Knowledge Limited | Dosing device |
US6673710B1 (en) | 2000-10-13 | 2004-01-06 | Bridge Semiconductor Corporation | Method of connecting a conductive trace and an insulative base to a semiconductor chip |
SE0100034D0 (sv) | 2001-01-04 | 2001-01-04 | Astrazeneca Ab | A delivery device |
GB2372543B (en) | 2001-02-23 | 2003-08-20 | Bespak Plc | Dosage counting devices |
GB2385640B (en) | 2001-02-23 | 2003-10-15 | Bespak Plc | Dosage counting devices |
GB2372542B (en) | 2001-02-23 | 2003-08-20 | Bespak Plc | Dosage counting devices |
GB0111329D0 (en) | 2001-05-01 | 2001-07-04 | Innovata Biomed Ltd | Device |
GB0111337D0 (en) | 2001-05-10 | 2001-07-04 | Innovata Biomed Ltd | Device |
FR2830527B1 (fr) | 2001-10-04 | 2004-08-27 | Valois Sa | Compteur de doses pour distributeur de produit fluide |
JP2005527508A (ja) * | 2002-03-07 | 2005-09-15 | ヴェクトゥラ リミテッド | 経口デリバリー用急速溶融多粒子製剤 |
US7004164B2 (en) | 2002-03-21 | 2006-02-28 | Trudell Medical International | Indicating device for aerosol container |
EP1369139A1 (en) | 2002-06-03 | 2003-12-10 | 3M Innovative Properties Company | Dose indicators and dispensing canister-indicator assemblies |
GB0214667D0 (en) | 2002-06-26 | 2002-08-07 | Aventis Pharma Ltd | Method and packaging for pressurized containers |
ATE326251T1 (de) | 2002-07-31 | 2006-06-15 | Chiesi Farma Spa | Pulverinhalator |
GB0222023D0 (en) | 2002-09-21 | 2002-10-30 | Aventis Pharma Ltd | Inhaler |
SE525061C2 (sv) | 2003-04-08 | 2004-11-23 | Ernst Hoerlins Ingenjoersbyraa | Räkneverk för räkning av doser |
GB0315509D0 (en) | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
US7703454B2 (en) | 2003-07-14 | 2010-04-27 | Vortran Medical Technology | Inhaler with breath actuated dose counter |
FR2857770B1 (fr) | 2003-07-18 | 2005-10-21 | Valois Sas | Indicateur de doses ameliore pour dispositif de distribution de produit fluide. |
FR2857769B1 (fr) | 2003-07-18 | 2005-10-21 | Valois Sa | Indicateur de doses ameliore pour dispositif de distribution de produit fluide. |
US7621273B2 (en) | 2003-10-28 | 2009-11-24 | Trudell Medical International | Indicating device with warning dosage indicator |
US7100530B2 (en) | 2003-12-15 | 2006-09-05 | Trudell Medical International, Inc. | Dose indicating device |
GB2414187B (en) | 2004-05-21 | 2007-03-07 | Bespak Plc | Dispensing apparatus |
US7543582B2 (en) | 2004-09-20 | 2009-06-09 | Trudell Medical International | Dose indicating device with display elements attached to container |
JP4525373B2 (ja) | 2005-02-03 | 2010-08-18 | トヨタ自動車株式会社 | 圧縮着火内燃機関の燃焼切替制御システム |
-
2005
- 2005-02-15 DK DK05708349.5T patent/DK1730676T3/da active
- 2005-02-15 AU AU2005215216A patent/AU2005215216B2/en active Active
- 2005-02-15 EP EP05708349.5A patent/EP1730676B1/en active Active
- 2005-02-15 BR BRPI0507714A patent/BRPI0507714B8/pt active IP Right Grant
- 2005-02-15 ES ES05708349T patent/ES2435397T3/es active Active
- 2005-02-15 NZ NZ548888A patent/NZ548888A/en unknown
- 2005-02-15 WO PCT/GB2005/000531 patent/WO2005079727A2/en active Application Filing
- 2005-02-15 MX MXPA06009133A patent/MXPA06009133A/es active IP Right Grant
- 2005-02-15 PT PT57083495T patent/PT1730676E/pt unknown
- 2005-02-15 JP JP2006552694A patent/JP4825138B2/ja active Active
- 2005-02-15 KR KR1020067019055A patent/KR101105909B1/ko active IP Right Grant
- 2005-02-15 CA CA002555347A patent/CA2555347A1/en not_active Abandoned
- 2005-02-15 PL PL05708349T patent/PL1730676T3/pl unknown
- 2005-02-15 US US10/597,551 patent/US8113199B2/en active Active
- 2005-02-15 SG SG200901106-5A patent/SG150524A1/en unknown
- 2005-02-15 SG SG200901107-3A patent/SG150525A1/en unknown
-
2006
- 2006-07-24 IL IL177042A patent/IL177042A/en active IP Right Grant
- 2006-09-06 NO NO20064006A patent/NO338541B1/no unknown
-
2007
- 2007-06-12 HK HK07106330.9A patent/HK1101722A1/xx unknown
-
2013
- 2013-10-25 CY CY20131100947T patent/CY1114641T1/el unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4525373Y1 (ja) * | 1967-03-22 | 1970-10-05 | ||
JPS4990567A (ja) * | 1972-12-06 | 1974-08-29 | ||
WO2004001664A1 (en) * | 2002-06-21 | 2003-12-31 | Glaxo Group Limited | Actuation indicator for a dispensing device |
Also Published As
Publication number | Publication date |
---|---|
SG150524A1 (en) | 2009-03-30 |
WO2005079727A3 (en) | 2005-12-01 |
WO2005079727A2 (en) | 2005-09-01 |
IL177042A0 (en) | 2006-12-10 |
NO20064006L (no) | 2006-09-15 |
SG150525A1 (en) | 2009-03-30 |
HK1101722A1 (en) | 2007-10-26 |
NO338541B1 (no) | 2016-09-05 |
US8113199B2 (en) | 2012-02-14 |
CA2555347A1 (en) | 2005-09-01 |
EP1730676A2 (en) | 2006-12-13 |
IL177042A (en) | 2014-03-31 |
BRPI0507714A (pt) | 2007-07-03 |
AU2005215216A1 (en) | 2005-09-01 |
KR101105909B1 (ko) | 2012-01-17 |
PT1730676E (pt) | 2013-10-31 |
BRPI0507714B8 (pt) | 2021-07-27 |
MXPA06009133A (es) | 2007-01-26 |
JP2007526562A (ja) | 2007-09-13 |
EP1730676B1 (en) | 2013-08-28 |
ES2435397T3 (es) | 2013-12-19 |
KR20060129057A (ko) | 2006-12-14 |
BRPI0507714B1 (pt) | 2020-08-18 |
AU2005215216B2 (en) | 2009-12-17 |
CY1114641T1 (el) | 2016-10-05 |
DK1730676T3 (da) | 2013-11-04 |
US20090139516A1 (en) | 2009-06-04 |
NZ548888A (en) | 2010-06-25 |
PL1730676T3 (pl) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4825138B2 (ja) | 薬剤ディスペンサー用カウンター | |
US7249687B2 (en) | Medicament dispenser | |
JP4405803B2 (ja) | 医薬ディスペンサー | |
JP4891545B2 (ja) | 薬物ディスペンサに薬剤キャリアを装填する方法 | |
US20190314587A1 (en) | Medicament dispenser | |
JP4384848B2 (ja) | 薬剤ディスペンサ | |
US20050247312A1 (en) | Medicament dispenser | |
JP2005506163A (ja) | 医薬ディスペンサー | |
JP2005523750A (ja) | 薬物分配器 | |
JP2005523748A (ja) | 薬物分配器 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071221 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110531 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110816 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110906 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110909 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4825138 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140916 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |